AVEO NASDAQ
AVEO Pharmaceuticals, Inc.
1W: +0.4%
1M: +0.7%
3M: +0.5%
1Y: +300.0%
3Y: +135.8%
5Y: -46.8%
$15.00
Last traded 2023-01-19 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$91M
Revenue
+256.0% YoY
$-41M
Net Income
+29.6% YoY
$-23M
Free Cash Flow
+61.0% YoY
87.0%
Gross Margin
-7.1%
Op. Margin
-14.3%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-101.2%
ROA-38.5%
ROIC196.0%
Valuation
P/E-8.4
P/B11.2
EV/EBITDA-7.6
Leverage
Debt/Equity1.34
Current Ratio2.37
Interest Cov.-9.3x
Quality Scores
Piotroski F3/9
Altman Z-6.74
Beneish M-2.31